Titre : Tymoviridae

Tymoviridae : Questions médicales fréquentes

Termes MeSH sélectionnés :

Randomized Controlled Trials as Topic
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Tymoviridae : Questions médicales les plus fréquentes", "headline": "Tymoviridae : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Tymoviridae : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-07-17", "dateModified": "2025-04-13", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Tymoviridae" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Virus à ARN à brin positif", "url": "https://questionsmedicales.fr/mesh/D000085102", "about": { "@type": "MedicalCondition", "name": "Virus à ARN à brin positif", "code": { "@type": "MedicalCode", "code": "D000085102", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "B04.820.578" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Tymovirus", "alternateName": "Tymovirus", "url": "https://questionsmedicales.fr/mesh/D017806", "about": { "@type": "MedicalCondition", "name": "Tymovirus", "code": { "@type": "MedicalCode", "code": "D017806", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "B04.820.578.984.850" } } } ], "about": { "@type": "MedicalCondition", "name": "Tymoviridae", "alternateName": "Tymoviridae", "code": { "@type": "MedicalCode", "code": "D046830", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Jermilia Charles", "url": "https://questionsmedicales.fr/author/Jermilia%20Charles", "affiliation": { "@type": "Organization", "name": "Department of Veterinary Microbiology and Preventive Medicine, College of Veterinary Medicine, 2116 Veterinary Medicine, Iowa State University, Ames, IA, 50011, USA." } }, { "@type": "Person", "name": "Chandra S Tangudu", "url": "https://questionsmedicales.fr/author/Chandra%20S%20Tangudu", "affiliation": { "@type": "Organization", "name": "Department of Veterinary Microbiology and Preventive Medicine, College of Veterinary Medicine, 2116 Veterinary Medicine, Iowa State University, Ames, IA, 50011, USA." } }, { "@type": "Person", "name": "Stefanie L Hurt", "url": "https://questionsmedicales.fr/author/Stefanie%20L%20Hurt", "affiliation": { "@type": "Organization", "name": "Department of Veterinary Microbiology and Preventive Medicine, College of Veterinary Medicine, 2116 Veterinary Medicine, Iowa State University, Ames, IA, 50011, USA." } }, { "@type": "Person", "name": "Charlotte Tumescheit", "url": "https://questionsmedicales.fr/author/Charlotte%20Tumescheit", "affiliation": { "@type": "Organization", "name": "Department of Pathology, University of Cambridge, Cambridge, UK." } }, { "@type": "Person", "name": "Andrew E Firth", "url": "https://questionsmedicales.fr/author/Andrew%20E%20Firth", "affiliation": { "@type": "Organization", "name": "Department of Pathology, University of Cambridge, Cambridge, UK." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Efficacy on gait and posture control after botulinum toxin A injection for lower-limb spasticity treatment after stroke: A randomized controlled trial.", "datePublished": "2023-01-16", "url": "https://questionsmedicales.fr/article/36726851", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3389/fnins.2022.1107688" } }, { "@type": "ScholarlyArticle", "name": "Application of Propofol Target-Controlled Infusion for Optimized Hemodynamic Status in ESRD Patients Receiving Arteriovenous Access Surgery: A Randomized Controlled Trial.", "datePublished": "2022-09-01", "url": "https://questionsmedicales.fr/article/36143879", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/medicina58091203" } }, { "@type": "ScholarlyArticle", "name": "Randomized trials of PSA screening.", "datePublished": "2024-06-25", "url": "https://questionsmedicales.fr/article/38926075", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.urolonc.2024.05.014" } }, { "@type": "ScholarlyArticle", "name": "Comparison of Efficacy of Pressure Controlled vs. Traditional Manual Mask Ventilation for Newborn Resuscitation - A Simulation-Based Pilot Randomized Control Trial.", "datePublished": "2023-11-28", "url": "https://questionsmedicales.fr/article/38012507", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s12098-023-04938-6" } }, { "@type": "ScholarlyArticle", "name": "The effect of acute and 14-day exogenous ketone supplementation on glycaemic control in adults with type 2 diabetes: two randomized controlled trials.", "datePublished": "2023-11-22", "url": "https://questionsmedicales.fr/article/37991451", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1152/ajpendo.00332.2023" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Virus", "item": "https://questionsmedicales.fr/mesh/D014780" }, { "@type": "ListItem", "position": 3, "name": "Virus à ARN", "item": "https://questionsmedicales.fr/mesh/D012328" }, { "@type": "ListItem", "position": 4, "name": "Virus à ARN à brin positif", "item": "https://questionsmedicales.fr/mesh/D000085102" }, { "@type": "ListItem", "position": 5, "name": "Tymoviridae", "item": "https://questionsmedicales.fr/mesh/D046830" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Tymoviridae - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Tymoviridae", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-11", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Tymoviridae", "description": "Comment diagnostiquer une infection par Tymoviridae ?\nQuels tests sont utilisés pour Tymoviridae ?\nLes symptômes aident-ils au diagnostic ?\nPeut-on isoler le virus en laboratoire ?\nY a-t-il des marqueurs spécifiques pour Tymoviridae ?", "url": "https://questionsmedicales.fr/mesh/D046830?mesh_terms=Randomized+Controlled+Trials+as+Topic&page=1000#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Tymoviridae", "description": "Quels sont les symptômes d'une infection par Tymoviridae ?\nLes symptômes sont-ils similaires chez tous les hôtes ?\nLes symptômes apparaissent-ils rapidement ?\nY a-t-il des symptômes spécifiques aux plantes ?\nLes symptômes sont-ils graves ?", "url": "https://questionsmedicales.fr/mesh/D046830?mesh_terms=Randomized+Controlled+Trials+as+Topic&page=1000#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Tymoviridae", "description": "Comment prévenir les infections par Tymoviridae ?\nLes mesures de quarantaine sont-elles efficaces ?\nFaut-il désinfecter les outils de jardinage ?\nLes semences peuvent-elles être contaminées ?\nY a-t-il des pratiques agricoles recommandées ?", "url": "https://questionsmedicales.fr/mesh/D046830?mesh_terms=Randomized+Controlled+Trials+as+Topic&page=1000#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Tymoviridae", "description": "Quel traitement est recommandé pour Tymoviridae ?\nLes antiviraux sont-ils efficaces contre Tymoviridae ?\nPeut-on vacciner contre Tymoviridae ?\nComment gérer les symptômes ?\nY a-t-il des traitements expérimentaux ?", "url": "https://questionsmedicales.fr/mesh/D046830?mesh_terms=Randomized+Controlled+Trials+as+Topic&page=1000#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Tymoviridae", "description": "Quelles complications peuvent survenir ?\nLes infections par Tymoviridae peuvent-elles être mortelles ?\nY a-t-il des complications à long terme ?\nLes animaux peuvent-ils développer des complications ?\nComment les complications sont-elles gérées ?", "url": "https://questionsmedicales.fr/mesh/D046830?mesh_terms=Randomized+Controlled+Trials+as+Topic&page=1000#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Tymoviridae", "description": "Quels sont les facteurs de risque pour Tymoviridae ?\nLes conditions climatiques influencent-elles le risque ?\nLes variétés de plantes jouent-elles un rôle ?\nLes insectes vecteurs sont-ils un facteur de risque ?\nLes pratiques de culture affectent-elles le risque ?", "url": "https://questionsmedicales.fr/mesh/D046830?mesh_terms=Randomized+Controlled+Trials+as+Topic&page=1000#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une infection par Tymoviridae ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic se fait par PCR ou sérologie pour détecter l'ARN viral." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour Tymoviridae ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les tests sérologiques et les techniques de biologie moléculaire sont courants." } }, { "@type": "Question", "name": "Les symptômes aident-ils au diagnostic ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes cliniques peuvent orienter vers une infection virale." } }, { "@type": "Question", "name": "Peut-on isoler le virus en laboratoire ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'isolement du virus peut être effectué sur des cultures cellulaires spécifiques." } }, { "@type": "Question", "name": "Y a-t-il des marqueurs spécifiques pour Tymoviridae ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Des anticorps spécifiques peuvent être détectés dans le sérum des hôtes infectés." } }, { "@type": "Question", "name": "Quels sont les symptômes d'une infection par Tymoviridae ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes varient, mais incluent souvent des troubles respiratoires ou digestifs." } }, { "@type": "Question", "name": "Les symptômes sont-ils similaires chez tous les hôtes ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Non, les symptômes peuvent varier selon l'hôte et le type de virus." } }, { "@type": "Question", "name": "Les symptômes apparaissent-ils rapidement ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes peuvent apparaître rapidement ou après une période d'incubation." } }, { "@type": "Question", "name": "Y a-t-il des symptômes spécifiques aux plantes ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les plantes peuvent montrer des décolorations ou des déformations des feuilles." } }, { "@type": "Question", "name": "Les symptômes sont-ils graves ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "La gravité des symptômes dépend de l'hôte et de la souche virale." } }, { "@type": "Question", "name": "Comment prévenir les infections par Tymoviridae ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "La prévention passe par des pratiques d'hygiène et la gestion des cultures." } }, { "@type": "Question", "name": "Les mesures de quarantaine sont-elles efficaces ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la quarantaine des plantes infectées aide à limiter la propagation du virus." } }, { "@type": "Question", "name": "Faut-il désinfecter les outils de jardinage ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, désinfecter les outils peut prévenir la transmission du virus entre les plantes." } }, { "@type": "Question", "name": "Les semences peuvent-elles être contaminées ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les semences peuvent être un vecteur de transmission du virus." } }, { "@type": "Question", "name": "Y a-t-il des pratiques agricoles recommandées ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Des pratiques comme la rotation des cultures et l'utilisation de variétés résistantes sont conseillées." } }, { "@type": "Question", "name": "Quel traitement est recommandé pour Tymoviridae ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Il n'existe pas de traitement antiviral spécifique, la prise en charge est symptomatique." } }, { "@type": "Question", "name": "Les antiviraux sont-ils efficaces contre Tymoviridae ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Les antiviraux classiques ne sont généralement pas efficaces contre cette famille de virus." } }, { "@type": "Question", "name": "Peut-on vacciner contre Tymoviridae ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Actuellement, il n'existe pas de vaccins disponibles pour les infections par Tymoviridae." } }, { "@type": "Question", "name": "Comment gérer les symptômes ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "La gestion des symptômes inclut des soins de soutien et des traitements symptomatiques." } }, { "@type": "Question", "name": "Y a-t-il des traitements expérimentaux ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Des recherches sont en cours pour développer des traitements antiviraux spécifiques." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent des pertes de rendement et des maladies secondaires chez les hôtes." } }, { "@type": "Question", "name": "Les infections par Tymoviridae peuvent-elles être mortelles ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Rarement, mais elles peuvent causer des dommages significatifs aux cultures." } }, { "@type": "Question", "name": "Y a-t-il des complications à long terme ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Des effets à long terme peuvent inclure une susceptibilité accrue à d'autres infections." } }, { "@type": "Question", "name": "Les animaux peuvent-ils développer des complications ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les animaux peuvent développer des complications liées à des infections virales secondaires." } }, { "@type": "Question", "name": "Comment les complications sont-elles gérées ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "La gestion des complications implique des soins appropriés et des traitements symptomatiques." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque pour Tymoviridae ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent la proximité d'autres plantes infectées et des pratiques agricoles inadéquates." } }, { "@type": "Question", "name": "Les conditions climatiques influencent-elles le risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des conditions climatiques favorables peuvent augmenter le risque d'infection." } }, { "@type": "Question", "name": "Les variétés de plantes jouent-elles un rôle ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Certaines variétés de plantes sont plus susceptibles aux infections par Tymoviridae." } }, { "@type": "Question", "name": "Les insectes vecteurs sont-ils un facteur de risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les insectes peuvent transmettre le virus d'une plante à une autre." } }, { "@type": "Question", "name": "Les pratiques de culture affectent-elles le risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Des pratiques de culture inadéquates peuvent augmenter le risque d'infection virale." } } ] } ] }

Sources (10000 au total)

Efficacy on gait and posture control after botulinum toxin A injection for lower-limb spasticity treatment after stroke: A randomized controlled trial.

To observe the efficacy of botulinum toxin type A (BoNT-A) for the spasticity of the lower-limb post-stroke on gait and posture control.... A total of 46 patients with hemiplegia gait were randomly divided into the experimental group (23 patients) and the control group (23 patients). In patients in the experimental group received injectio... At 1, 4, and 12 weeks after treatment, the L-FMA, stride length, speed, and TUGT significantly improved than 0 week in both groups. The L-FMA and peak of forefoot pressure, and MAS results in the expe... Botulinum toxin type A injection can improve motor functions of the lower limb, gait, spasticity, forefoot pressure, and posture control of patients after stroke....

Application of Propofol Target-Controlled Infusion for Optimized Hemodynamic Status in ESRD Patients Receiving Arteriovenous Access Surgery: A Randomized Controlled Trial.

Background and Objectives: End-stage renal disease (ESRD) is associated with increased anesthetic risks such as cardiovascular events resulting in higher perioperative mortality rates. This study inve...

Randomized trials of PSA screening.

The role of prostate-specific antigen (PSA) testing in prostate cancer (PCa) screening has evolved over recent decades with multiple randomized controlled trials (RCTs) spurring guideline changes. At ... We summarize findings from primary RCTs investigating PSA screening's impact on PCa mortality and incidence: the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial, the European Ran... The PLCO Trial randomized men to annual PSA and DRE screening or usual care, reporting no significant difference in PCa mortality between groups at 17 years (RR 0.93, [95% CI: 0.81-1.08]), yet signifi... While the CAP and initial PLCO trials showed no significant reduction in PCa mortality, the ERSPC demonstrated a 21% reduction at 13 years, with further benefits at extended follow-up. Differences in ...

Comparison of Efficacy of Pressure Controlled vs. Traditional Manual Mask Ventilation for Newborn Resuscitation - A Simulation-Based Pilot Randomized Control Trial.

To determine efficacy of non-invasive positive pressure face mask ventilation using a ventilator device (NIPPmV) for achieving early effective ventilation compared to that by self-inflating bag (SIB) ... The authors video recorded 33 trained resuscitators using NIPPmV (provided using ventilator device), SIB [a 500 ml silicone SIB without a positive end expiratory pressure (PEEP) valve] and a TPR. Usin... Total 99 videos were recorded. The time(s) taken to achieve the first chest rise was significantly lesser in NIPPmV group compared to SIB and TPR (3.0 ± 1.7 vs. 3.7 ± 1.9 vs. 7.5 ± 5.4, respectively, ... The non-invasive positive pressure face mask ventilation using a ventilator (NIPPmV) resulted in achieving early, effective and consistent ventilation....

Effects of continuous glucose monitoring on glycaemic control in type 2 diabetes: A systematic review and network meta-analysis of randomized controlled trials.

The aim of this study was to assess the efficacy of continuous glucose monitoring (CGM) versus self-monitoring of blood glucose (SMBG) in maintaining glycaemic control among people with type 2 diabete... The protocol was registered in PROSPERO (CRD42023387583). PubMed, Web of Science, EMBASE and OVID databases were searched from 1 January 2000 until 31 December 2022 for randomized controlled trials co... Eleven high-quality studies, involving 1425 individuals with T2DM, were identified. Traditional meta-analysis revealed that CGM exhibited a significantly decreased [mean difference (MD): -0.31, 95% co... CGM could provide T2DM with greater benefits in glycaemic management compared with SMBG, particularly in patients using real-time CGM. These findings provide an updated perspective on previous researc...

The Effects of Core Stabilization Exercises on Respiratory Muscle Strength, Respiratory Functions, and Postural Control in Children With Hearing Loss: A Randomized Controlled Trial.

To evaluate the effects of core stabilization training on respiratory muscle strength, respiratory functions, and postural control in children with hearing loss.... We conducted a randomized controlled trial at Bezmialem Vakif University, Faculty of Health Sciences, Division of Physiotherapy and Rehabilitation. Thirty children with hearing loss who were diagnosed... In the study group, a significant improvement was observed in force vital capacity, peak expiratory flow of the spirometry test, maximum inspiratory pressure/expiratory pressure (MEP) of the respirato... Core stabilization exercises were effective in improving respiratory muscle strength, spirometry, and postural control in children with hearing loss....

Virtual reality increases pressure pain threshold and lowers anxiety in children compared with control and non-immersive control-A randomized, crossover trial.

Virtual reality (VR) is a promising non-pharmacological pain intervention because it may not only distract but also modulate pain by immersing the user in a three-dimensional 360° alternate reality. I... Seventy-two children (mean age 10.2 (6-14) years) were randomized to 24 sequences of four interventions (immersive VR Game, immersive VR video, tablet: 2D video and control: small talk). Outcome measu... PPT increased significantly during VR game (PPTdiff): 136 kPa (CI 112; 161), p < 0.0001 and VR Video (PPTdiff): 122 kPa (CI 91; 153), p < 0.0001. Also, anxiety levels significantly decreased during bo... VR had a marked beneficial effect on PPT and anxiety compared with the control interventions: 2D video and small talk. Thus, immersive VR had a distinct modulatory effect on pain and anxiety in a well... Paediatric immersive VR seems to be beneficial although well-controlled studies are pending. We investigated whether immersive VR can modulate children's threshold for pain and anxiety level in an exp...

Implementing Infection Control and Quality of Life Best Practices in Nursing Homes With Project ECHO: Protocol for a Patient-Centered Randomized Controlled Trial.

Nursing homes in the United States were devastated by COVID-19, with 710,000 cases and 138,000 deaths nationally through October 2021. Although facilities are required to have infection control staff,... Our study seeks to answer the research question of how evidence-based infection control guidelines can be implemented effectively in nursing homes, including comparing the effectiveness of two ECHO-de... A stratified cluster randomized design was utilized. Using a 1:1 ratio, we randomly assigned 136 nursing homes to ECHO or ECHO Plus arms. Randomization was stratified by geographic location, baseline ... A total of 290 nursing home facilities were assessed for eligibility, with 136 nursing homes recruited and randomly assigned to ECHO or ECHO Plus. Guided by the Reach, Effectiveness, Adoption, Impleme... A multipronged approach to improving infection control and emergency preparedness in nursing homes is important, given the toll that the COVID-19 pandemic has taken on residents and staff. The ECHO mo... ClinicalTrials.gov NCT04499391; https://clinicaltrials.gov/ct2/show/NCT04499391....

Study protocol of a multicentre double-blind RCT, comparing a traditional RCT with an aggregated N-of-1 trial: GAG therapy Efficacy Trial Solution for Bladder pain syndrome/Interstitial cystitis (GETSBI study).

Obtaining level 1 evidence on efficacy of glycosaminoglycan (GAG) therapy is difficult, due to low incidence of bladder pain syndrome/interstitial cystitis (BPS/IC) and heterogeneous symptoms experien... The GETSBI study is a double-blind multidesign multicentre randomised placebo-controlled study to assess the short-term and long-term efficacy of hyaluronic acid (1.6%) + chondroitin sulfate (2%) ther... Ethical approval was given by METC Oost-Nederland, file number: 2020-7265, NL-number: NL76290.091.20. Findings from this study will be disseminated via publication, reports and conference presentation... ClinicalTrials.gov identifier (NCT number): NCT05518864....